Collection

COVID-19 vaccination programme

Documents relating to the new coronavirus (COVID-19) vaccination programme.

From:
UK Health Security Agency
Published
27 November 2020
Last updated
1422 December 2021 — See all updates

Blood clotting, myocarditis and pericarditis, and Guillain-Barré Syndrome (GBS)

See the COVID-19 vaccination and rare side effects for information and guidance on these very rare conditions reported after COVID-19 vaccination.

Coronaviruses are a large family of viruses that cause respiratory infections. These can range from the common cold to more serious diseases.

COVID-19 is caused by a new form of coronavirus known as SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2). It was first reported in December 2019.

Pregnant women who are inadvertently immunised should be notified to the Vaccine in Pregnancy surveillance programme.

Further information is available on NHS.UK and on GOV.UK

Blood clotting, myocarditis and pericarditis, and Guillain-Barré Syndrome (GBS)

See the COVID-19 vaccination and rare side effects for information and guidance on these very rare conditions reported after COVID-19 vaccination.

Guidance

Training resources

COVID-19 vaccination training slide set

COVID-19 vaccination e-learning programme

Consent forms and letters

Accessing COVID-19 vaccination without an NHS number

Leaflets, posters and resources

A MMR, MenACWY and COVID-19 vaccines communications toolkit for universities is available to download.

Social media resources promoting COVID-19 vaccination in migrant communities in London and nationally are available to download.

Social media resources promoting COVID-19 vaccination for pregnant women are available to download.

Surveillance

Protocols and patient group directions (PGDs)

The PGDs to support the COVID-19 vaccination programme are available to download:

PGD for COVID-19 Comirnaty® (Pfizer/BioNTech)

PGD for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech)

PGD for COVID-19 Vaccine AstraZeneca, (ChAdOx1-S [recombinant])

PGD for COVID-19 Vaccine Moderna

Programme documents

Published 27 November 2020
Last updated 1422 December 2021 + show all updates

  2. Added 'Suspension of the 15-minute wait for vaccination with mRNA vaccine for COVID-19: UK CMOs opinion' and 'COVID-19 vaccination observation period'.

  4. Added COVID-19 vaccination in pregnancy surveillance.

  5. Updated 'Programme documents' section.

  6. Added monitoring reports of the effectiveness of COVID-19 vaccination.

  8. Added 'COVID-19 vaccination: checklist for parents of children aged 12 to 15 years'.

  10. Added COVID-19 vaccine weekly surveillance reports.

  11. Added COVID-19: provision of immunisation sessions for outbreaks in schools.

  12. Added COVID-19 vaccination: consent form for children and young people or parents.

  13. Updated COVID-19 vaccination training slide set.

  14. Added COVID-19 vaccination: booster dose resources.

  16. Added COVID-19 vaccination: easy-read resources for children and young people.

  18. Added Third primary COVID-19 vaccine dose for people who are immunosuppressed: JCVI advice.

  20. Added link to Comirnaty® PGD.

  22. Added link to the COVID-19 vaccination and rare side effects.

  30. Updated COVID-19 vaccination training slide set.

  31. Added link to the COVID-19 Vaccine Moderna PGD.

  34. Added 'Use of the AstraZeneca COVID-19 vaccine: JCVI statement, 7 May 2021'.

  35. Updated COVID-19 vaccination training slide set.

  37. Added Use of the AstraZeneca COVID-19 vaccine: JCVI statement and link to COVID-19 vaccination and blood clotting document collection.

  38. Added 'COVID-19 vaccination: booking an appointment letter' and 'Letter from the Health and Social Care Secretary on COVID-19 vaccination phase 1 advice'.

  39. Added 'Priority groups for phase 2 of the COVID-19 vaccination programme: advice from the JCVI'.

  40. Added updated COVID-19 vaccination training slide set link, 'PHE monitoring of the effectiveness of COVID-19 vaccination' and 'Letter from the Health and Social Care Secretary on COVID-19 vaccination in people with learning disabilities'.

  41. Added easy-read consent form for adults and vaccine product information poster.

  42. COVID-19 vaccination training slide set updated.

  43. Added British Sign Language resources.

  45. Added the use of human and animal products in vaccines guide.

  46. Added 'COVID-19 vaccine monitoring reports' to the surveillance section.

  49. Added National protocol for COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]).

  50. Added easy-read resources.

  51. Added link to the COVID-19 Vaccine AstraZeneca (ChAdOx1-S [recombinant]) PGD.

  52. Added: Revised COVID-19 vaccination training slide set and Priority groups for COVID-19 vaccination: advice from the JCVI, 30 December 2020.

  53. Added national protocol for COVID-19 mRNA vaccine BNT162b2 (Pfizer/BioNTech).

  54. Training slide set updated.

  55. Training slide set updated.

  58. Added 'COVID-19 vaccination: women of childbearing age, pregnant, planning a pregnancy or breastfeeding'.

  60. First published.

Contents